Curida secured NOK 75M from Canica, Klaveness Marine and Investinor

Curida, an Elverum, Norway-based pharma manufacturer, announced the completion of a capital raise totalling NOK 75M ($9.5M).

The funding was provided by investors from Norway, namely Canica, Klaveness Marine and Investinor, each contributing with NOK 25 million.

Curida, led by CEO Leif Rune Skymoen, was founded in 2015 a result of an employee and management buy-out of the former Takeda and Nycomed manufacturing site in Elverum, Norway. The company manufactures and exports liquid pharmaceuticals and has 90 employees.